Immunodominant PstS1 antigen of <Emphasis Type="Italic">mycobacterium tuberculosis</Emphasis> is a potent biological response modifier for the treatment of bladder cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer

Authors:	Christian?S?nger,Andreas?Busche,Gabriele?Bentien,Ralf?Spallek,Fatima?Jonas,Andreas?B?hle,Mahavir?Singh,Sven?Brandau author-information" > author-information__contact u-icon-before" > mailto:sbrandau@fz-borstel.de" title=" sbrandau@fz-borstel.de" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author

Affiliation:	1.Division of Immunotherapy,Research Center Borstel,Borstel,Germany;2.LIONEX Diagnostics & Therapeutics GmbH,Braunschweig,Germany;3.Helios Agnes Karll Hospital,Bad Schwartau,Germany

Abstract:	Background Bacillus Calmette Guérin (BCG)-immunotherapy has a well-documented and successful clinical history in the treatment of bladder cancer. However, regularly observed side effects, a certain degree of nonresponders and restriction to superficial cancers remain a major obstacle. Therefore, alternative treatment strategies are intensively being explored.

Keywords:
本文献已被 SpringerLink 等数据库收录！